SUTTER_LOGO.png
Sutter Rock Capital Corp. Announces Additional Adjustment to Conversion Rate for Convertible Notes
December 31, 2019 16:30 ET | Sutter Rock Capital Corp.
SAN FRANCISCO, Dec. 31, 2019 (GLOBE NEWSWIRE) -- Sutter Rock Capital Corp. (“Sutter Rock” or the “Company”) (Nasdaq:SSSS) today announced an adjustment to the conversion rate of its 4.75%...
SUTTER_LOGO.png
Sutter Rock Capital Corp. Announces Adjustment of Conversion Rate for Convertible Notes
December 06, 2019 08:00 ET | Sutter Rock Capital Corp.
SAN FRANCISCO, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Sutter Rock Capital Corp. (“Sutter Rock” or the “Company”) (Nasdaq:SSSS) today announced an adjustment to the conversion rate of its 4.75%...
View Systems Logo.png
View Systems, Inc.’s (VSYM) Sannabis Announces Initiation Yesterday of Hemp Program with a Maximum Security Prison in Colombia for Inmates to Make Products for Sale into the US$ 13 Billion Industrial Hemp Market.
October 17, 2019 10:27 ET | VIEW SYSTEMS INC
Company also reports elimination yesterday of a convertible note causing recent downward pressure on their stock. Cali, Colombia, Oct. 17, 2019 (GLOBE NEWSWIRE) -- View Systems, Inc. (VSYM)...
Verus International Signs $600,000 Note – Provides Operational Update
May 01, 2019 16:53 ET | Verus International, Inc.
Gaithersburg, MD, May 01, 2019 (GLOBE NEWSWIRE) -- Verus International, Inc. (“Verus” or the “Company”) (OTCPink:VRUS) is pleased to announce that it has strengthened its capital structure via a...
4 Vytex Logo-size.jpg
Vystar Gains 1st Institutional Investor with $200K Investment at $0.15/Share
March 07, 2019 08:15 ET | Vystar Corp
WORCESTER, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Vystar Corporation, (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Therapeutics Announces Unsecured $120.5M Convertible Note Financing
March 27, 2018 08:00 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento"), announced today that it has entered into a securities purchase agreement to sell $120.5 million...